Bridging the gap to clinical translation: the advanced role of PET molecular imaging in stem cell therapy
European Journal of Nuclear Medicine and Molecular Imaging · 2026-07 · 53 (8) · 4803-4806
DOI: 10.1007/s00259-026-07859-6 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 25.03.2026. Verfasst von Peili Cen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, Zhejiang, 3100…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Stem Cell Transplantation, Molecular Imaging, Translational Research, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Postdoctoral Fellowship Program of China Postdoctoral Science Foundation.
Abstract (Originalsprache)
In the past few decades, stem cell therapy has achieved remarkable progress in preclinical and clinical trials, especially for treating major diseases, such as stroke, Parkinson’s disease (PD), myocardial infarction, diabetes, etc (Temple, Cell Stem Cell 30:512-29, 2023). However, the current challenge in clinical translation lies in the difficulty in non-invasively, dynamically, and quantitatively assessing the survival, proliferation, homing, migration, and function of stem cells in vivo. This lack of assessment leads to inconsistent therapeutic effects, unclear mechanisms, and difficulties in optimizing dosages (Hussen et al., Int J Surg. 110:8002-24, 2024). Positron emission tomography (PET), with its superior sensitivity and quantitative capability, is an ideal technology to visualize and monitor stem cells in vivo. Also, as an advanced tool of precision medicine, PET molecular imaging can accurately evaluate the therapeutic efficacy and predict the outcome of stem cell therapy (Cen et al., Eur J Nucl Med Mol Imaging 53:71-92, 2025). It integrates individual features, cellular properties, and dynamic biomarkers, achieving personalized strategies of stem cell therapy with maximized efficacy and minimized risks in clinical practice. Thus, PET plays a key role in bridging the gap to clinical translation and accelerate clinical practice of stem cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Nuclear Medicine, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
- Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
- Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University, Hangzhou, Zhejiang, 310009, China.
- Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, Zhejiang, 310014, China.
- Department of Nuclear Medicine, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China. yanzhong@zju.edu.cn.
ORCID-Profile: Peili Cen, Hong Zhang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of China Postdoctoral Science Foundation
- Priority-Funded Postdoctoral Research Project, Zhejiang Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Cen, P., Jin, C., Wang, J., Zhou, R., Zhong, Y., Tian, M., & Zhang, H. (2026). Bridging the gap to clinical translation: the advanced role of PET molecular imaging in stem cell therapy. European Journal of Nuclear Medicine and Molecular Imaging, 53(8), 4803-4806. https://doi.org/10.1007/s00259-026-07859-6
Vancouver
Cen P, Jin C, Wang J, Zhou R, Zhong Y, Tian M, et al. Bridging the gap to clinical translation: the advanced role of PET molecular imaging in stem cell therapy. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(8):4803-4806. doi:10.1007/s00259-026-07859-6
BibTeX
@article{Cen2026,
author = {Cen, Peili and Jin, Chentao and Wang, Jing and Zhou, Rui and Zhong, Yan and Tian, Mei and Zhang, Hong},
title = {Bridging the gap to clinical translation: the advanced role of PET molecular imaging in stem cell therapy},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {8},
pages = {4803--4806},
doi = {10.1007/s00259-026-07859-6}
}
EUVIMED